
Results
4
4 companies
EZZ Life Science Holdings
Market Cap: AU$114.2m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia.
EZZ
AU$2.42
7D
1.7%
1Y
-14.2%
Mesoblast
Market Cap: AU$3.0b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$2.33
7D
1.7%
1Y
47.9%
Clinuvel Pharmaceuticals
Market Cap: AU$558.2m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$11.12
7D
0.9%
1Y
-18.1%
Immutep
Market Cap: AU$412.1m
A biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia.
IMM
AU$0.28
7D
9.8%
1Y
-11.1%